Magnificent 7 Technology Stocks Face Sharp Pullback Amid AI Spending Concerns, Despite Strong Demand Fundamentals

Magnificent 7 Technology Stocks Face Sharp Pullback Amid AI Spending Concerns, Despite Strong Demand Fundamentals

Phillip Research Team

24 Jul 2026  |    5 views

Market Performance and Key Concerns

The Magnificent 7 technology stocks experienced a significant pullback in June 2026, declining 8.5% compared to May’s positive 5.4% performance. This sharp reversal saw the group substantially underperform both the S&P 500, which fell 1.1%, and the NASDAQ, which declined 2.8%. The decline was primarily driven by investor concerns over the substantial artificial intelligence spending commitments from major hyperscalers, including Microsoft (-17%), Meta (-11%), Amazon (-12%), and Google (-6%).

These concerns were amplified by the four hyperscalers raising approximately US$139 billion in bonds during the first half of 2026, representing a 35% increase from their total bond issuances in 2025. Additional uncertainty emerged following the appointment of new Federal Reserve Chair Kevin Warsh in May, raising speculation about potential interest rate increases that could elevate AI financing costs.


Individual Stock Performance

Microsoft emerged as the biggest laggard, falling 17% after providing aggressive capital expenditure guidance of US$190 billion for fiscal year 2026, which exceeded consensus estimates of US$155 billion by 23%. This increase was attributed to higher-than-expected component prices driven by surging memory costs. Meta declined 11% amid reports that the company was considering raising tens of billions in equity funding to support its capital expenditure plans.


Fundamental Demand Remains Strong

Despite market concerns, research indicates that hyperscaler capital expenditure decisions are fundamentally sound, driven by genuine organic demand rather than speculative supply planning. The combined first quarter 2026 backlog for Microsoft, Google, and Amazon increased 46% year-over-year to US$873 billion, excluding deals with Anthropic and OpenAI. These partnerships, estimated at US$580 billion, are excluded from organic growth calculations due to their long-term nature of more than five years and associated execution and funding risks.

The US$873 billion organic backlog serves as a reliable indicator of short-to-medium term AI demand from enterprises and sovereign nations, with the majority expected to be recognised within the next two years. Google noted that cloud revenue could have been higher if capacity constraints hadn’t limited its ability to meet enterprise demand, whilst Amazon’s Trainium chips are nearly fully subscribed and Microsoft anticipates capacity constraints continuing through 2026.


Investment Outlook

The research maintains an overweight recommendation on the Magnificent 7, noting that June’s pullback reduced forward price-to-earnings valuations to 38.4 times from May’s 39.7 times. The underperformance reflects broader investor rotation away from mega-cap technology stocks with high AI spending towards more attractively valued defensive sector names.


Frequently Asked Questions

Q: How did the Magnificent 7 perform in June 2026 compared to broader markets?

A: The Magnificent 7 declined 8.5% in June 2026, significantly underperforming the S&P 500, which fell -1.1% and NASDAQ, which declined -2.8%, marking a sharp reversal from May's positive 5.4% performance.

Q: What were the main concerns driving the sell-off?

A: Investors were primarily concerned about high AI spending by hyperscalers, with the four major companies raising US$139 billion in bonds in the first half of 2026, 35% higher than their total 2025 bond issuances. Additional uncertainty arose from potential Fed rate hikes under new Chair Kevin Warsh.

Q: Which stock was the worst performer and why?

A: Microsoft was the biggest laggard, falling 17% due to aggressive capex guidance of US$190 billion for FY2026, which was 23% higher than consensus estimates of US$155 billion, driven by surging memory costs.

Q: What evidence supports continued AI demand?

A: The combined 1Q26 backlog of Microsoft, Google, and Amazon increased 46% year-over-year to US$873 billion, excluding Anthropic/OpenAI deals, indicating strong organic demand from enterprises and sovereign nations.

Q: Why are Anthropic and OpenAI deals excluded from organic growth assumptions?

A: These deals, estimated at US$580 billion, are long-term commitments exceeding five years that carry significant execution and funding risks, with both companies currently unprofitable and relying on external capital rather than operating cash flow.

Q: What is the current investment recommendation for the Magnificent 7?

A: The research maintains an overweight recommendation, noting that June's pullback reduced forward P/E valuations to 38.4 times from May's 39.7 times, making the group more attractively valued.

Q: What capacity constraints are hyperscalers experiencing?

A: Google mentioned cloud revenue could have been higher if it had been able to meet enterprise demand, Amazon's Trainium chips are almost fully subscribed, and Microsoft expects to be capacity-constrained at least through 2026.

 

This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.

 

Disclaimer

These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Related Articles

US-Domiciled ETFs Vs Ireland-Domiciled (UCITS) ETFs: Which Is Better For Singapore Investors?

Why Your Dividend Looks Smaller Than Expected Imagine checking your brokerage account after a dividend...

  24 Jul 2026  |    14 views

Netflix Upgraded to BUY on Strong Engagement and Pricing Power Despite Softer Guidance

Company Overview Netflix Inc. operates as the world’s leading streaming entertainment service, providing original and...

  24 Jul 2026  |    3 views

Wells Fargo Delivers Strong Growth with 12% Loan Expansion, BUY Rating and US$115 Target Price

Company Overview Wells Fargo & Company is one of America’s largest financial institutions, operating across...

  24 Jul 2026  |    2 views

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com